Loading...
•
Jan 31, 2024
Phreesia Q4 2024 Earnings Report
Phreesia reported strong momentum going into fiscal year 2025.
Key Takeaways
Phreesia announced its Q4 Fiscal Year 2024 results, with total revenue reaching $95.0 million, a 24% increase year-over-year. The company facilitated over 150 million patient visits in fiscal 2024 and is focusing on continued growth and a return to profitability.
Total revenue was $95.0 million, up 24% year-over-year.
Average number of healthcare services clients (AHSCs) was 3,962, up 26% year-over-year.
Healthcare services revenue per AHSC was $17,456, down 1% year-over-year.
Net loss was $30.6 million, compared to $38.0 million in the same period in the prior year.
Revenue by Segment
Forward Guidance
Phreesia is maintaining its revenue outlook for fiscal year 2025 at a range of $424 million to $434 million, implying year-over-year growth of 19% to 22%. The company is updating its Adjusted EBITDA outlook for fiscal year 2025 to a range of $12 million to $20 million from a previous range of $10 million to $20 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...